Melatonin Treatment for Newborn Infants With Moderate to Severe Hypoxic Ischemic Encephalopathy

NCT01904786 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of enrollment of suitable candidates

Conditions

Newborn Hypoxic Ischemic Encephalopathy

Interventions

DRUG: Melatonin
DRUG: placebo

Sponsor

St. Louis University